Internationale Publikationen
Hier stellen wir eine Auswahl wissenschaftlicher Veröffentlichungen zur Verfügung, die im Zusammenhang mit der IOZK-Immuntherapie stehen.
Sie können mit Hilfe der Filter eine Auswahl nach Tumorarten und Methoden treffen, oder Suchbegriffe eingeben.
Immune and clinical outcomes in patients with stage IV melanoma vaccinated with peptide-pulsed dendritic cells derived from CD34+ progenitors and activated with type I interferon
/in International Publications, Malignant Melanoma /von 2005-09-01 / J. Immunother. 2005 Sep-Oct;28(5):505-16[Vaccine therapy of prostate cancer]
/in International Publications, Prostate Cancer /von 2005-09-01 / Aktuelle Urol 2005 Sep;36(5):407-16B-cell lymphoma and myeloma protection induced by idiotype vaccination with dendritic cells is mediated entirely by T cells in mice
/in International Publications, Malignant Lymphoma /von 2005-09-01 / J. Immunother. 2005 Sep-Oct;28(5):461-6Vaccination of advanced hepatocellular carcinoma patients with tumor lysate-pulsed dendritic cells: a clinical trial
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2005-09-01 / J. Immunother. 2005 Sep-Oct;28(5):496-504Allogeneic dendritic cells pulsed with tumor lysates or apoptotic bodies as immunotherapy for patients with early-stage B-cell chronic lymphocytic leukemia
/in Chronic Leukemia, Dendritic Cells, International Publications /von 2005-09-01 / Leukemia 2005 Sep;19(9):1621-7[Current status of hyperthermia for therapy of brain tumor]
/in Glioblastoma, International Publications /von 2005-09-01 / Nippon Rinsho 2005 Sep;63 Suppl 9:483-9Immune-related effects of local hyperthermia in patients with primary liver cancer
/in Hepatocellular Carcinoma, International Publications /von 2005-09-01 / Hepatogastroenterology 2005 Sep-Oct;52(65):1502-6Immunomodulatory dendritic cells require autologous serum to circumvent nonspecific immunosuppressive activity in vivo
/in Dendritic Cells, International Publications /von 2005-08-23 / Blood 2005 Dec;106(13):4225-33Antitumor activity of a fusion of esophageal carcinoma cells with dendritic cells derived from cord blood
/in Esophageal Carcinoma, International Publications /von 2005-08-18 / Vaccine 2005 Nov;23(45):5225-30First results of triple-modality treatment combining radiotherapy, chemotherapy, and hyperthermia for the treatment of patients with stage IIB, III, and IVA cervical carcinoma
/in Cervical Cancer, International Publications /von 2005-08-15 / Cancer 2005 Aug;104(4):763-70Prognostic significance of CD83 positive, mature dendritic cells in the gallbladder carcinoma
/in Gallbladder Cancer, International Publications /von 2005-08-01 / Oncol. Rep. 2005 Aug;14(2):353-6Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment
/in Dendritic Cells, Glioblastoma, International Publications /von 2005-08-01 / Clin. Cancer Res. 2005 Aug;11(15):5515-25Tumor-targeted gene transfer in vivo via recombinant Newcastle disease virus modified by a bispecific fusion protein
/in International Publications, Newcastle Disease Virus /von 2005-08-01 / Int. J. Oncol. 2005 Aug;27(2):377-84Immunotherapy in multiple myeloma–possibility or probability?
/in International Publications, Malignant Lymphoma /von 2005-08-01 / Br. J. Haematol. 2005 Aug;130(3):344-62Dynamic control of lymphocyte trafficking by fever-range thermal stress
/in Hyperthermia, International Publications /von 2005-07-26 / Cancer Immunol. Immunother. 2006 Mar;55(3):299-311Induction of cellular immune responses against carcinoembryonic antigen in patients with metastatic tumors after vaccination with altered peptide ligand-loaded dendritic cells
/in Colorectal Cancer, International Publications, NSCLC /von 2005-07-21 / Cancer Immunol. Immunother. 2006 Mar;55(3):268-76Dendritic cell-mediated cross-presentation of antigens derived from colon carcinoma cells exposed to a highly cytotoxic multidrug regimen with gemcitabine, oxaliplatin, 5-fluorouracil, and leucovorin, elicits a powerful human antigen-specific CTL response with antitumor activity in vitro
/in Colorectal Cancer, International Publications /von 2005-07-15 / J. Immunol. 2005 Jul;175(2):820-8Adjuvant IL-15 does not enhance the efficacy of tumor cell lysate-pulsed dendritic cell vaccines for active immunotherapy of T cell lymphoma
/in International Publications, Malignant Lymphoma /von 2005-07-15 / Cancer Immunol. Immunother. 2006 Apr;55(4):420-32Dendritic cells and vascular endothelial growth factor in colorectal cancer: correlations with clinicobiological findings
/in Colorectal Cancer, International Publications /von 2005-07-07 / Oncology 2005;68(2-3):276-84Therapeutic vaccination against murine lymphoma by intratumoral injection of naive dendritic cells
/in International Publications, Malignant Lymphoma /von 2005-07-01 / Cancer Res. 2005 Jul;65(13):5958-64